×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
概要
This event will be conducted online via Zoom.
Click Here to View the Program
We are offering a reduced participation fee for attendees from outside Japan. To claim this rate, please complete the registration form (see program link above) and email to DIA Japan at: japan@diaglobal.org
Featured
Want to learn more about DIA Global Oncology Development 2021? You've come to the right site!
プログラム委員会
-
Toshihiko Doi, MD, PhD Deputy Director / Chief, Experimental Therapeutics
National Cancer Center Hospital East, Japan -
Noboru Yamamoto, MD, PhD Deputy Director, Department of Experimental Therapeutics
National Cancer Center Hospital, Japan -
Masakazu Hirata, MD, PhD Clinical Reviewer, Division of RS Consultation, Kansai Branch
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Toshiko Ishibashi, PhD, RN Oncology Medical Science Department, Medical Affairs Division
Daiichi Sankyo Co., Ltd., Japan -
Eri Sekine Executive Vice President
CMIC Group, Japan -
Takuya Suzuki Associate Director, Japan anad Asia Clinical Development Department
Eisai Co., Ltd., Japan -
Tomoko Takami Director, Oncology Clinical Development, Oncology Science Unit
MSD K.K., Japan -
Atsushi Tsukamoto, PhD, MSc Head is Therapeutic Area Strategies
Daiichi Sankyo, United States -
Hironobu Saito, PhD Specially Appointed Professor
Tottori University, Chromosome Egineering Research Center, Japan -
Junko Sato, PhD Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
